List of Tables
Table 1. Global Nuclear Radiopharmaceutical Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)
Table 2. Major Manufacturers of Diagnostic
Table 3. Major Manufacturers of Therapeutic
Table 4. Global Nuclear Radiopharmaceutical Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)
Table 5. Global Nuclear Radiopharmaceutical Revenue Grow Rate (CAGR) by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 6. Global Nuclear Radiopharmaceutical Revenue by Region (2019-2024) & (US$ Million)
Table 7. Global Nuclear Radiopharmaceutical Revenue by Region (2025-2030) & (US$ Million)
Table 8. Global Nuclear Radiopharmaceutical Revenue Market Share by Region (2019-2024)
Table 9. Global Nuclear Radiopharmaceutical Revenue Market Share by Region (2025-2030)
Table 10. Global Nuclear Radiopharmaceutical Sales Grow Rate (CAGR) by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 11. Global Nuclear Radiopharmaceutical Sales by Region (2019-2024) & (Units)
Table 12. Global Nuclear Radiopharmaceutical Sales by Region (2025-2030) & (Units)
Table 13. Global Nuclear Radiopharmaceutical Sales Market Share by Region (2019-2024)
Table 14. Global Nuclear Radiopharmaceutical Sales Market Share by Region (2025-2030)
Table 15. Global Nuclear Radiopharmaceutical Sales by Manufacturers (2019-2024) & (Units)
Table 16. Global Nuclear Radiopharmaceutical Sales Share by Manufacturers (2019-2024)
Table 17. Global Nuclear Radiopharmaceutical Revenue by Manufacturers (2019-2024) & (US$ Million)
Table 18. Global Nuclear Radiopharmaceutical Revenue Share by Manufacturers (2019-2024)
Table 19. Global Key Players of Nuclear Radiopharmaceutical, Industry Ranking, 2022 VS 2023 VS 2024
Table 20. Nuclear Radiopharmaceutical Price by Manufacturers 2019-2024 (US$/Unit)
Table 21. Global Nuclear Radiopharmaceutical Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 22. Global Nuclear Radiopharmaceutical by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Nuclear Radiopharmaceutical as of 2023)
Table 23. Global Key Manufacturers of Nuclear Radiopharmaceutical, Manufacturing Base Distribution and Headquarters
Table 24. Global Key Manufacturers of Nuclear Radiopharmaceutical, Product Offered and Application
Table 25. Global Key Manufacturers of Nuclear Radiopharmaceutical, Date of Enter into This Industry
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global Nuclear Radiopharmaceutical Sales by Type (2019-2024) & (Units)
Table 28. Global Nuclear Radiopharmaceutical Sales by Type (2025-2030) & (Units)
Table 29. Global Nuclear Radiopharmaceutical Sales Share by Type (2019-2024)
Table 30. Global Nuclear Radiopharmaceutical Sales Share by Type (2025-2030)
Table 31. Global Nuclear Radiopharmaceutical Revenue by Type (2019-2024) & (US$ Million)
Table 32. Global Nuclear Radiopharmaceutical Revenue by Type (2025-2030) & (US$ Million)
Table 33. Global Nuclear Radiopharmaceutical Revenue Share by Type (2019-2024)
Table 34. Global Nuclear Radiopharmaceutical Revenue Share by Type (2025-2030)
Table 35. Nuclear Radiopharmaceutical Price by Type (2019-2024) & (US$/Unit)
Table 36. Global Nuclear Radiopharmaceutical Price Forecast by Type (2025-2030) & (US$/Unit)
Table 37. Global Nuclear Radiopharmaceutical Sales by Application (2019-2024) & (Units)
Table 38. Global Nuclear Radiopharmaceutical Sales by Application (2025-2030) & (Units)
Table 39. Global Nuclear Radiopharmaceutical Sales Share by Application (2019-2024)
Table 40. Global Nuclear Radiopharmaceutical Sales Share by Application (2025-2030)
Table 41. Global Nuclear Radiopharmaceutical Revenue by Application (2019-2024) & (US$ Million)
Table 42. Global Nuclear Radiopharmaceutical Revenue by Application (2025-2030) & (US$ Million)
Table 43. Global Nuclear Radiopharmaceutical Revenue Share by Application (2019-2024)
Table 44. Global Nuclear Radiopharmaceutical Revenue Share by Application (2025-2030)
Table 45. Nuclear Radiopharmaceutical Price by Application (2019-2024) & (US$/Unit)
Table 46. Global Nuclear Radiopharmaceutical Price Forecast by Application (2025-2030) & (US$/Unit)
Table 47. US & Canada Nuclear Radiopharmaceutical Sales by Type (2019-2024) & (Units)
Table 48. US & Canada Nuclear Radiopharmaceutical Sales by Type (2025-2030) & (Units)
Table 49. US & Canada Nuclear Radiopharmaceutical Revenue by Type (2019-2024) & (US$ Million)
Table 50. US & Canada Nuclear Radiopharmaceutical Revenue by Type (2025-2030) & (US$ Million)
Table 51. US & Canada Nuclear Radiopharmaceutical Sales by Application (2019-2024) & (Units)
Table 52. US & Canada Nuclear Radiopharmaceutical Sales by Application (2025-2030) & (Units)
Table 53. US & Canada Nuclear Radiopharmaceutical Revenue by Application (2019-2024) & (US$ Million)
Table 54. US & Canada Nuclear Radiopharmaceutical Revenue by Application (2025-2030) & (US$ Million)
Table 55. US & Canada Nuclear Radiopharmaceutical Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 56. US & Canada Nuclear Radiopharmaceutical Revenue by Country (2019-2024) & (US$ Million)
Table 57. US & Canada Nuclear Radiopharmaceutical Revenue by Country (2025-2030) & (US$ Million)
Table 58. US & Canada Nuclear Radiopharmaceutical Sales by Country (2019-2024) & (Units)
Table 59. US & Canada Nuclear Radiopharmaceutical Sales by Country (2025-2030) & (Units)
Table 60. Europe Nuclear Radiopharmaceutical Sales by Type (2019-2024) & (Units)
Table 61. Europe Nuclear Radiopharmaceutical Sales by Type (2025-2030) & (Units)
Table 62. Europe Nuclear Radiopharmaceutical Revenue by Type (2019-2024) & (US$ Million)
Table 63. Europe Nuclear Radiopharmaceutical Revenue by Type (2025-2030) & (US$ Million)
Table 64. Europe Nuclear Radiopharmaceutical Sales by Application (2019-2024) & (Units)
Table 65. Europe Nuclear Radiopharmaceutical Sales by Application (2025-2030) & (Units)
Table 66. Europe Nuclear Radiopharmaceutical Revenue by Application (2019-2024) & (US$ Million)
Table 67. Europe Nuclear Radiopharmaceutical Revenue by Application (2025-2030) & (US$ Million)
Table 68. Europe Nuclear Radiopharmaceutical Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 69. Europe Nuclear Radiopharmaceutical Revenue by Country (2019-2024) & (US$ Million)
Table 70. Europe Nuclear Radiopharmaceutical Revenue by Country (2025-2030) & (US$ Million)
Table 71. Europe Nuclear Radiopharmaceutical Sales by Country (2019-2024) & (Units)
Table 72. Europe Nuclear Radiopharmaceutical Sales by Country (2025-2030) & (Units)
Table 73. China Nuclear Radiopharmaceutical Sales by Type (2019-2024) & (Units)
Table 74. China Nuclear Radiopharmaceutical Sales by Type (2025-2030) & (Units)
Table 75. China Nuclear Radiopharmaceutical Revenue by Type (2019-2024) & (US$ Million)
Table 76. China Nuclear Radiopharmaceutical Revenue by Type (2025-2030) & (US$ Million)
Table 77. China Nuclear Radiopharmaceutical Sales by Application (2019-2024) & (Units)
Table 78. China Nuclear Radiopharmaceutical Sales by Application (2025-2030) & (Units)
Table 79. China Nuclear Radiopharmaceutical Revenue by Application (2019-2024) & (US$ Million)
Table 80. China Nuclear Radiopharmaceutical Revenue by Application (2025-2030) & (US$ Million)
Table 81. Asia Nuclear Radiopharmaceutical Sales by Type (2019-2024) & (Units)
Table 82. Asia Nuclear Radiopharmaceutical Sales by Type (2025-2030) & (Units)
Table 83. Asia Nuclear Radiopharmaceutical Revenue by Type (2019-2024) & (US$ Million)
Table 84. Asia Nuclear Radiopharmaceutical Revenue by Type (2025-2030) & (US$ Million)
Table 85. Asia Nuclear Radiopharmaceutical Sales by Application (2019-2024) & (Units)
Table 86. Asia Nuclear Radiopharmaceutical Sales by Application (2025-2030) & (Units)
Table 87. Asia Nuclear Radiopharmaceutical Revenue by Application (2019-2024) & (US$ Million)
Table 88. Asia Nuclear Radiopharmaceutical Revenue by Application (2025-2030) & (US$ Million)
Table 89. Asia Nuclear Radiopharmaceutical Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 90. Asia Nuclear Radiopharmaceutical Revenue by Region (2019-2024) & (US$ Million)
Table 91. Asia Nuclear Radiopharmaceutical Revenue by Region (2025-2030) & (US$ Million)
Table 92. Asia Nuclear Radiopharmaceutical Sales by Region (2019-2024) & (Units)
Table 93. Asia Nuclear Radiopharmaceutical Sales by Region (2025-2030) & (Units)
Table 94. Middle East, Africa and Latin America Nuclear Radiopharmaceutical Sales by Type (2019-2024) & (Units)
Table 95. Middle East, Africa and Latin America Nuclear Radiopharmaceutical Sales by Type (2025-2030) & (Units)
Table 96. Middle East, Africa and Latin America Nuclear Radiopharmaceutical Revenue by Type (2019-2024) & (US$ Million)
Table 97. Middle East, Africa and Latin America Nuclear Radiopharmaceutical Revenue by Type (2025-2030) & (US$ Million)
Table 98. Middle East, Africa and Latin America Nuclear Radiopharmaceutical Sales by Application (2019-2024) & (Units)
Table 99. Middle East, Africa and Latin America Nuclear Radiopharmaceutical Sales by Application (2025-2030) & (Units)
Table 100. Middle East, Africa and Latin America Nuclear Radiopharmaceutical Revenue by Application (2019-2024) & (US$ Million)
Table 101. Middle East, Africa and Latin America Nuclear Radiopharmaceutical Revenue by Application (2025-2030) & (US$ Million)
Table 102. Middle East, Africa and Latin America Nuclear Radiopharmaceutical Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 103. Middle East, Africa and Latin America Nuclear Radiopharmaceutical Revenue by Country (2019-2024) & (US$ Million)
Table 104. Middle East, Africa and Latin America Nuclear Radiopharmaceutical Revenue by Country (2025-2030) & (US$ Million)
Table 105. Middle East, Africa and Latin America Nuclear Radiopharmaceutical Sales by Country (2019-2024) & (Units)
Table 106. Middle East, Africa and Latin America Nuclear Radiopharmaceutical Sales by Country (2025-2030) & (Units)
Table 107. Nihon Medi-Physics Co.,Ltd. Company Information
Table 108. Nihon Medi-Physics Co.,Ltd. Description and Major Businesses
Table 109. Nihon Medi-Physics Co.,Ltd. Nuclear Radiopharmaceutical Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 110. Nihon Medi-Physics Co.,Ltd. Nuclear Radiopharmaceutical Product Model Numbers, Pictures, Descriptions and Specifications
Table 111. Nihon Medi-Physics Co.,Ltd. Recent Developments
Table 112. Curium Pharma Company Information
Table 113. Curium Pharma Description and Major Businesses
Table 114. Curium Pharma Nuclear Radiopharmaceutical Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 115. Curium Pharma Nuclear Radiopharmaceutical Product Model Numbers, Pictures, Descriptions and Specifications
Table 116. Curium Pharma Recent Developments
Table 117. Cardinal Health Company Information
Table 118. Cardinal Health Description and Major Businesses
Table 119. Cardinal Health Nuclear Radiopharmaceutical Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 120. Cardinal Health Nuclear Radiopharmaceutical Product Model Numbers, Pictures, Descriptions and Specifications
Table 121. Cardinal Health Recent Developments
Table 122. Bayer Global Company Information
Table 123. Bayer Global Description and Major Businesses
Table 124. Bayer Global Nuclear Radiopharmaceutical Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 125. Bayer Global Nuclear Radiopharmaceutical Product Model Numbers, Pictures, Descriptions and Specifications
Table 126. Bayer Global Recent Developments
Table 127. GE Healthcare Company Information
Table 128. GE Healthcare Description and Major Businesses
Table 129. GE Healthcare Nuclear Radiopharmaceutical Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 130. GE Healthcare Nuclear Radiopharmaceutical Product Model Numbers, Pictures, Descriptions and Specifications
Table 131. GE Healthcare Recent Developments
Table 132. Mallinckrodt Pharmaceuticals Company Information
Table 133. Mallinckrodt Pharmaceuticals Description and Major Businesses
Table 134. Mallinckrodt Pharmaceuticals Nuclear Radiopharmaceutical Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 135. Mallinckrodt Pharmaceuticals Nuclear Radiopharmaceutical Product Model Numbers, Pictures, Descriptions and Specifications
Table 136. Mallinckrodt Pharmaceuticals Recent Developments
Table 137. Bracco Group Company Information
Table 138. Bracco Group Description and Major Businesses
Table 139. Bracco Group Nuclear Radiopharmaceutical Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 140. Bracco Group Nuclear Radiopharmaceutical Product Model Numbers, Pictures, Descriptions and Specifications
Table 141. Bracco Group Recent Developments
Table 142. Advanced Molecular-imaging Solution Company Information
Table 143. Advanced Molecular-imaging Solution Description and Major Businesses
Table 144. Advanced Molecular-imaging Solution Nuclear Radiopharmaceutical Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 145. Advanced Molecular-imaging Solution Nuclear Radiopharmaceutical Product Model Numbers, Pictures, Descriptions and Specifications
Table 146. Advanced Molecular-imaging Solution Recent Developments
Table 147. China Isotope & Radiation Company Information
Table 148. China Isotope & Radiation Description and Major Businesses
Table 149. China Isotope & Radiation Nuclear Radiopharmaceutical Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 150. China Isotope & Radiation Nuclear Radiopharmaceutical Product Model Numbers, Pictures, Descriptions and Specifications
Table 151. China Isotope & Radiation Recent Developments
Table 152. Ciaeriar Company Information
Table 153. Ciaeriar Description and Major Businesses
Table 154. Ciaeriar Nuclear Radiopharmaceutical Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 155. Ciaeriar Nuclear Radiopharmaceutical Product Model Numbers, Pictures, Descriptions and Specifications
Table 156. Ciaeriar Recent Developments
Table 157. Shanghai Atom Kexing Pharmaceutical Co.,Ltd. Company Information
Table 158. Shanghai Atom Kexing Pharmaceutical Co.,Ltd. Description and Major Businesses
Table 159. Shanghai Atom Kexing Pharmaceutical Co.,Ltd. Nuclear Radiopharmaceutical Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 160. Shanghai Atom Kexing Pharmaceutical Co.,Ltd. Nuclear Radiopharmaceutical Product Model Numbers, Pictures, Descriptions and Specifications
Table 161. Shanghai Atom Kexing Pharmaceutical Co.,Ltd. Recent Developments
Table 162. Key Raw Materials Lists
Table 163. Raw Materials Key Suppliers Lists
Table 164. Nuclear Radiopharmaceutical Distributors List
Table 165. Nuclear Radiopharmaceutical Customers List
Table 166. Nuclear Radiopharmaceutical Market Trends
Table 167. Nuclear Radiopharmaceutical Market Drivers
Table 168. Nuclear Radiopharmaceutical Market Challenges
Table 169. Nuclear Radiopharmaceutical Market Restraints
Table 170. Research Programs/Design for This Report
Table 171. Key Data Information from Secondary Sources
Table 172. Key Data Information from Primary Sources
List of Figures
Figure 1. Nuclear Radiopharmaceutical Product Picture
Figure 2. Global Nuclear Radiopharmaceutical Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)
Figure 3. Global Nuclear Radiopharmaceutical Market Share by Type in 2023 & 2030
Figure 4. Diagnostic Product Picture
Figure 5. Therapeutic Product Picture
Figure 6. Global Nuclear Radiopharmaceutical Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)
Figure 7. Global Nuclear Radiopharmaceutical Market Share by Application in 2023 & 2030
Figure 8. Oncology
Figure 9. Thyroid
Figure 10. Cardiology
Figure 11. Others
Figure 12. Nuclear Radiopharmaceutical Report Years Considered
Figure 13. Global Nuclear Radiopharmaceutical Revenue, (US$ Million), 2019 VS 2023 VS 2030
Figure 14. Global Nuclear Radiopharmaceutical Revenue 2019-2030 (US$ Million)
Figure 15. Global Nuclear Radiopharmaceutical Revenue Market Share by Region in Percentage: 2023 Versus 2030
Figure 16. Global Nuclear Radiopharmaceutical Revenue Market Share by Region (2019-2030)
Figure 17. Global Nuclear Radiopharmaceutical Sales 2019-2030 ((Units)
Figure 18. Global Nuclear Radiopharmaceutical Sales Market Share by Region (2019-2030)
Figure 19. US & Canada Nuclear Radiopharmaceutical Sales YoY (2019-2030) & (Units)
Figure 20. US & Canada Nuclear Radiopharmaceutical Revenue YoY (2019-2030) & (US$ Million)
Figure 21. Europe Nuclear Radiopharmaceutical Sales YoY (2019-2030) & (Units)
Figure 22. Europe Nuclear Radiopharmaceutical Revenue YoY (2019-2030) & (US$ Million)
Figure 23. China Nuclear Radiopharmaceutical Sales YoY (2019-2030) & (Units)
Figure 24. China Nuclear Radiopharmaceutical Revenue YoY (2019-2030) & (US$ Million)
Figure 25. Asia (excluding China) Nuclear Radiopharmaceutical Sales YoY (2019-2030) & (Units)
Figure 26. Asia (excluding China) Nuclear Radiopharmaceutical Revenue YoY (2019-2030) & (US$ Million)
Figure 27. Middle East, Africa and Latin America Nuclear Radiopharmaceutical Sales YoY (2019-2030) & (Units)
Figure 28. Middle East, Africa and Latin America Nuclear Radiopharmaceutical Revenue YoY (2019-2030) & (US$ Million)
Figure 29. The Nuclear Radiopharmaceutical Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2023
Figure 30. The Top 5 and 10 Largest Manufacturers of Nuclear Radiopharmaceutical in the World: Market Share by Nuclear Radiopharmaceutical Revenue in 2023
Figure 31. Global Nuclear Radiopharmaceutical Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 32. Global Nuclear Radiopharmaceutical Sales Market Share by Type (2019-2030)
Figure 33. Global Nuclear Radiopharmaceutical Revenue Market Share by Type (2019-2030)
Figure 34. Global Nuclear Radiopharmaceutical Sales Market Share by Application (2019-2030)
Figure 35. Global Nuclear Radiopharmaceutical Revenue Market Share by Application (2019-2030)
Figure 36. US & Canada Nuclear Radiopharmaceutical Sales Market Share by Type (2019-2030)
Figure 37. US & Canada Nuclear Radiopharmaceutical Revenue Market Share by Type (2019-2030)
Figure 38. US & Canada Nuclear Radiopharmaceutical Sales Market Share by Application (2019-2030)
Figure 39. US & Canada Nuclear Radiopharmaceutical Revenue Market Share by Application (2019-2030)
Figure 40. US & Canada Nuclear Radiopharmaceutical Revenue Share by Country (2019-2030)
Figure 41. US & Canada Nuclear Radiopharmaceutical Sales Share by Country (2019-2030)
Figure 42. U.S. Nuclear Radiopharmaceutical Revenue (2019-2030) & (US$ Million)
Figure 43. Canada Nuclear Radiopharmaceutical Revenue (2019-2030) & (US$ Million)
Figure 44. Europe Nuclear Radiopharmaceutical Sales Market Share by Type (2019-2030)
Figure 45. Europe Nuclear Radiopharmaceutical Revenue Market Share by Type (2019-2030)
Figure 46. Europe Nuclear Radiopharmaceutical Sales Market Share by Application (2019-2030)
Figure 47. Europe Nuclear Radiopharmaceutical Revenue Market Share by Application (2019-2030)
Figure 48. Europe Nuclear Radiopharmaceutical Revenue Share by Country (2019-2030)
Figure 49. Europe Nuclear Radiopharmaceutical Sales Share by Country (2019-2030)
Figure 50. Germany Nuclear Radiopharmaceutical Revenue (2019-2030) & (US$ Million)
Figure 51. France Nuclear Radiopharmaceutical Revenue (2019-2030) & (US$ Million)
Figure 52. U.K. Nuclear Radiopharmaceutical Revenue (2019-2030) & (US$ Million)
Figure 53. Italy Nuclear Radiopharmaceutical Revenue (2019-2030) & (US$ Million)
Figure 54. Russia Nuclear Radiopharmaceutical Revenue (2019-2030) & (US$ Million)
Figure 55. China Nuclear Radiopharmaceutical Sales Market Share by Type (2019-2030)
Figure 56. China Nuclear Radiopharmaceutical Revenue Market Share by Type (2019-2030)
Figure 57. China Nuclear Radiopharmaceutical Sales Market Share by Application (2019-2030)
Figure 58. China Nuclear Radiopharmaceutical Revenue Market Share by Application (2019-2030)
Figure 59. Asia Nuclear Radiopharmaceutical Sales Market Share by Type (2019-2030)
Figure 60. Asia Nuclear Radiopharmaceutical Revenue Market Share by Type (2019-2030)
Figure 61. Asia Nuclear Radiopharmaceutical Sales Market Share by Application (2019-2030)
Figure 62. Asia Nuclear Radiopharmaceutical Revenue Market Share by Application (2019-2030)
Figure 63. Asia Nuclear Radiopharmaceutical Revenue Share by Region (2019-2030)
Figure 64. Asia Nuclear Radiopharmaceutical Sales Share by Region (2019-2030)
Figure 65. Japan Nuclear Radiopharmaceutical Revenue (2019-2030) & (US$ Million)
Figure 66. South Korea Nuclear Radiopharmaceutical Revenue (2019-2030) & (US$ Million)
Figure 67. China Taiwan Nuclear Radiopharmaceutical Revenue (2019-2030) & (US$ Million)
Figure 68. Southeast Asia Nuclear Radiopharmaceutical Revenue (2019-2030) & (US$ Million)
Figure 69. India Nuclear Radiopharmaceutical Revenue (2019-2030) & (US$ Million)
Figure 70. Middle East, Africa and Latin America Nuclear Radiopharmaceutical Sales Market Share by Type (2019-2030)
Figure 71. Middle East, Africa and Latin America Nuclear Radiopharmaceutical Revenue Market Share by Type (2019-2030)
Figure 72. Middle East, Africa and Latin America Nuclear Radiopharmaceutical Sales Market Share by Application (2019-2030)
Figure 73. Middle East, Africa and Latin America Nuclear Radiopharmaceutical Revenue Market Share by Application (2019-2030)
Figure 74. Middle East, Africa and Latin America Nuclear Radiopharmaceutical Revenue Share by Country (2019-2030)
Figure 75. Middle East, Africa and Latin America Nuclear Radiopharmaceutical Sales Share by Country (2019-2030)
Figure 76. Brazil Nuclear Radiopharmaceutical Revenue (2019-2030) & (US$ Million)
Figure 77. Mexico Nuclear Radiopharmaceutical Revenue (2019-2030) & (US$ Million)
Figure 78. Turkey Nuclear Radiopharmaceutical Revenue (2019-2030) & (US$ Million)
Figure 79. Israel Nuclear Radiopharmaceutical Revenue (2019-2030) & (US$ Million)
Figure 80. GCC Countries Nuclear Radiopharmaceutical Revenue (2019-2030) & (US$ Million)
Figure 81. Nuclear Radiopharmaceutical Value Chain
Figure 82. Nuclear Radiopharmaceutical Production Process
Figure 83. Channels of Distribution
Figure 84. Distributors Profiles
Figure 85. Bottom-up and Top-down Approaches for This Report
Figure 86. Data Triangulation
Figure 87. Key Executives Interviewed